- Rating
- 2
- Confidence
- 3
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper proposes MOSST, a training-free pipeline that segments and names tissue regions in H&E images of spatial transcriptomics (Xenium) samples. For each tissue microarray (TMA), genes are clustered by spatial co-expression into modules, and the top-scoring regions of each module give box-and-point prompts to SAM3, applied to the H&E image and to a FICTURE factor map. An H&E-only branch adds candidates where FICTURE signal is weak, and the candidates are selected by SAM3 score, prompt stability, and overlap without using tissue-region annotations. GPT-6 then assigns each candidate one of twelve tissue classes from H&E and a Cell Map, which shows biologist-annotated cell types around the candidate contour. On ten lung TMAs with 75 annotated regions, 37/75 regions are both localized and correctly classified at IoU ≥ 0.10 (13/75 at IoU ≥ 0.50). In a separate experiment with candidates held fixed, adding the Cell Map to H&E raises correct classifications from 33/63 to 42/63, and it outperforms a cell-composition text input (35/63). The authors state that precise boundary delineation and generalization beyond the evaluated cohort need further validation.
Critical strengths
-
The pipeline needs no training. The selection parameters were set on a separate Visium HD dataset and then fixed for the ten Xenium TMAs.
-
The paper describes implementation details such as the SAM3 checkpoint, the selection procedure, and the metrics in the appendix, and states that prompts and code are provided in the supplement.
Critical weaknesses
-
The practical value of the setting is unclear, and the Cell Map result is hard to interpret. The method needs measured spatial transcriptomics: the GeneMap and the FICTURE map both come from the transcript counts, and the H&E branch that fills in weak-signal areas is defined by the absence of FICTURE signal, so it cannot run without transcriptomics either. The best performance also needs the Cell Map, which is built from biologist-provided cell-type annotations. In the fixed-candidate experiment, adding it raises correct classifications from 33/63 to 42/63 (9 of the 42 correct predictions, about 21%), but these annotations already hint at the tissue structure, and the authors acknowledge that the experiment does not separate spatial arrangement from cell-type identity. Producing both inputs is likely to cost more than drawing the tissue regions directly on H&E, yet the paper does not say in which situation obtaining tissue names and outlines this way is worthwhile. This matters because the whole contribution rests on these inputs being worth their cost, and the paper does not show that.
-
The evaluation is too weak to support the claims. The abstract reports only 37/75 at IoU ≥ 0.10, where a 10% overlap counts as a match. At IoU ≥ 0.50 the number drops to 13/75, so boundary accuracy is not adequately validated. The study also uses only ten lung tissue microarrays (TMAs), 75 ground-truth regions (63 in the recognition experiment), and a single cohort, so generalization to other tissues or datasets is not shown. This matters because with this scale and this criterion the reported numbers cannot show that the method works reliably.
Questions for authors
-
How stable are the results when GPT-6 is called repeatedly? The requests do not set temperature, top-p, or a seed, and each input condition uses only one response per candidate. Could you report the variation of the main results (e.g., 37/75 and 42/63) across repeated runs?
-
What happens if the cell-type annotations for the Cell Map are predicted by an off-the-shelf model instead of using the biologist-provided annotations?
-
In what practical situation is this method better than annotating the tissue regions directly? How does it compare with existing spatial-domain methods?
Response to Reviewer xen5
We thank Reviewer xen5 for a thoughtful review, and in particular for raising practical value and stability. Both led to new experiments in the revision; point-by-point replies follow.
W1/Q3. Practical value and cost of the inputs. Thank you for raising this; we agree that practicality is central for adoption.
The molecular information also improves segmentation itself: molecular prompts find 71.2% of regions, against 60.6% for the same number of grid prompts.
W2. Evaluation strength. We have strengthened the evaluation in two ways.
Q1. Stability of repeated GPT calls. Thank you for this suggestion.
Q2. Predicted instead of biologist-provided cell types. We have run this comparison on the same 52 found regions (found with GeneMap-only candidates). Correct class first:
End to end on the final candidates, the fully annotation-free pipeline finds and correctly names 51.5% of the 66 regions, against 50.0% with expert cell types.
We hope these additions address the reviewer's questions, and we are happy to discuss any further points. If the concerns are resolved, we would be grateful if the assessment could reflect this.